Zoe McArdle1, Reetu R Singh1, Helle Bielefeldt-Ohmann2,3, Karen M Moritz4, Michiel F Schreuder5, Kate M Denton6. 1. Cardiovascular Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia. 2. School of Veterinary Science, The University of Queensland, Gatton, Queensland, Australia. 3. School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland, Australia. 4. Child Health Research Centre and School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia. 5. Department of Pediatric Nephrology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands. 6. Cardiovascular Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia Kate.Denton@monash.edu.
Abstract
BACKGROUND: Children born with a solitary functioning kidney (SFK) are predisposed to develop hypertension and kidney injury. Glomerular hyperfiltration and hypertrophy contribute to the pathophysiology of kidney injury. Angiotensin-converting enzyme inhibition (ACEi) can mitigate hyperfiltration and may be therapeutically beneficial in reducing progression of kidney injury in those with an SFK. METHODS: SFK was induced in male sheep fetuses at 100 days gestation (term=150 days). Between 4 and 8 weeks of age, SFK lambs received enalapril (SFK+ACEi; 0.5mg/kg per day, once daily, orally) or vehicle (SFK). At 8 months, we examined BP, basal kidney function, renal functional reserve (RFR; GFR response to combined amino acid and dopamine infusion), GFR response to nitric oxide synthase (NOS) inhibition, and basal nitric oxide (NO) bioavailability (basal urinary total nitrate and nitrite [NOx]). RESULTS: SFK+ACEi prevented albuminuria and resulted in lower basal GFR (16%), higher renal blood flow (approximately 22%), and lower filtration fraction (approximately 35%), but similar BP, compared with vehicle-treated SFK sheep. Together with greater recruitment of RFR (approximately 14%) in SFK+ACEi than SFK animals, this indicates a reduction in glomerular hyperfiltration-mediated kidney dysfunction. During NOS inhibition, the decrease in GFR (approximately 14%) was greater among SFK+ACEi than among SFK animals. Increased (approximately 85%) basal urinary total NOx in SFK+ACEi compared with SFK animals indicates elevated NO bioavailability likely contributed to improvements in kidney function and prevention of albuminuria. CONCLUSIONS: Brief and early ACEi in SFK is associated with reduced glomerular hyperfiltration-mediated kidney disease up to 8 months of age in a sheep model.
BACKGROUND: Children born with a solitary functioning kidney (SFK) are predisposed to develop hypertension and kidney injury. Glomerular hyperfiltration and hypertrophy contribute to the pathophysiology of kidney injury. Angiotensin-converting enzyme inhibition (ACEi) can mitigate hyperfiltration and may be therapeutically beneficial in reducing progression of kidney injury in those with an SFK. METHODS: SFK was induced in male sheep fetuses at 100 days gestation (term=150 days). Between 4 and 8 weeks of age, SFK lambs received enalapril (SFK+ACEi; 0.5mg/kg per day, once daily, orally) or vehicle (SFK). At 8 months, we examined BP, basal kidney function, renal functional reserve (RFR; GFR response to combined amino acid and dopamine infusion), GFR response to nitric oxide synthase (NOS) inhibition, and basal nitric oxide (NO) bioavailability (basal urinary total nitrate and nitrite [NOx]). RESULTS: SFK+ACEi prevented albuminuria and resulted in lower basal GFR (16%), higher renal blood flow (approximately 22%), and lower filtration fraction (approximately 35%), but similar BP, compared with vehicle-treated SFK sheep. Together with greater recruitment of RFR (approximately 14%) in SFK+ACEi than SFK animals, this indicates a reduction in glomerular hyperfiltration-mediated kidney dysfunction. During NOS inhibition, the decrease in GFR (approximately 14%) was greater among SFK+ACEi than among SFK animals. Increased (approximately 85%) basal urinary total NOx in SFK+ACEi compared with SFK animals indicates elevated NO bioavailability likely contributed to improvements in kidney function and prevention of albuminuria. CONCLUSIONS: Brief and early ACEi in SFK is associated with reduced glomerular hyperfiltration-mediated kidney disease up to 8 months of age in a sheep model.
Authors: Alemayehu H Jufar; Yugeesh R Lankadeva; Clive N May; Andrew D Cochrane; Rinaldo Bellomo; Roger G Evans Journal: Am J Physiol Regul Integr Comp Physiol Date: 2020-10-14 Impact factor: 3.619
Authors: Sarah L Walton; Marc Q Mazzuca; Marianne Tare; Helena C Parkington; Mary E Wlodek; Karen M Moritz; Linda A Gallo Journal: Pharmacol Res Date: 2018-06-02 Impact factor: 7.658
Authors: Simone Sanna-Cherchi; Pietro Ravani; Valentina Corbani; Stefano Parodi; Riccardo Haupt; Giorgio Piaggio; Maria L Degli Innocenti; Danio Somenzi; Antonella Trivelli; Gianluca Caridi; Claudia Izzi; Francesco Scolari; Girolamo Mattioli; Landino Allegri; Gian Marco Ghiggeri Journal: Kidney Int Date: 2009-06-17 Impact factor: 10.612